These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4258924)

  • 61. Actinomycin D and x-radiation suppression of spontaneous tumorigenesis in mice.
    Mason JM; Jennings BR
    J Reticuloendothel Soc; 1974 Feb; 15(2):96-111. PubMed ID: 4815216
    [No Abstract]   [Full Text] [Related]  

  • 62. In vivo antitumor activity and other pharmacological properties of halitoxin obtained from the sponge Haliclona viridis.
    Baslow MH; Turlapaty P
    Proc West Pharmacol Soc; 1969; 12():6-8. PubMed ID: 5812303
    [No Abstract]   [Full Text] [Related]  

  • 63. Natural antibodies against the Ehrlich ascites mouse tumour in sera of irradiated goats, identified by complement consumption.
    Oravec C; Cambelová J
    Neoplasma; 1971; 18(2):161-72. PubMed ID: 5577314
    [No Abstract]   [Full Text] [Related]  

  • 64. Transplantability and antigenicity of two sublines of the TA3 tumor.
    Sanford BH; Codington JF; Jeanloz RW; Palmer PD
    J Immunol; 1973 May; 110(5):1233-7. PubMed ID: 4572632
    [No Abstract]   [Full Text] [Related]  

  • 65. Demonstration of antibody in rabbit feces after active or passive parenteral immunization.
    McCleery JL; Kraft SC; Rothberg RM
    Digestion; 1970; 3(4):213-21. PubMed ID: 5469636
    [No Abstract]   [Full Text] [Related]  

  • 66. Studies of structure and immunosuppression of cross-reactive idiotype in strain A mice.
    Nisonoff A; Ju ST; Owen FL
    Immunol Rev; 1977; 34():89-118. PubMed ID: 66785
    [No Abstract]   [Full Text] [Related]  

  • 67. Antibody-mediated immunity to transplantable tumors following reovirus oncolysis.
    Klein PA
    Pathol Microbiol (Basel); 1967; 30(2):222-45. PubMed ID: 4291735
    [No Abstract]   [Full Text] [Related]  

  • 68. ONCOLYSIS BY CLOSTRIDIA. I. ACTIVITY OF CLOSTRIDIUM BUTYRICUM (M-55) AND OTHER NONPATHOGENIC CLOSTRIDIA AGAINST THE EHRLICH CARCINOMA.
    MOESE JR; MOESE G
    Cancer Res; 1964 Feb; 24():212-6. PubMed ID: 14115686
    [No Abstract]   [Full Text] [Related]  

  • 69. [Studies on human sera for antibodies against Clostridium butyricum strain Jean H 8].
    Mehnert WH; Luther P
    Acta Biol Med Ger; 1975; 34(9):1557-9. PubMed ID: 1221742
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Effect of prednisolone and glycyrrhizin on passive transfer in experimental allergic encephalomyelitis].
    Kuroyanagi T; Saito M
    Arerugi; 1966 Feb; 15(2):67-74. PubMed ID: 4163807
    [No Abstract]   [Full Text] [Related]  

  • 71. [Immunological treatment of cancer--a review].
    Iwamori S
    Saishin Igaku; 1970 May; 25(5):1089-102. PubMed ID: 4192795
    [No Abstract]   [Full Text] [Related]  

  • 72. Delimitation of inhibitory and enhancing effect of histone on tumor growth.
    Gillissen G; Schweizer K
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1972; 77(1):57-63. PubMed ID: 4259985
    [No Abstract]   [Full Text] [Related]  

  • 73. IMMUNITY TO TRANSPLANTABLE TUMORS FOLLOWING VIRAL ONCOLYSIS.II. ANTIGENIC SIMILARITIES BETWEEN THREE UNSPECIFIC MOUSE TUMORS.
    LINDENMANN J; KLEIN PA
    J Immunol; 1965 Mar; 94():461-6. PubMed ID: 14279800
    [No Abstract]   [Full Text] [Related]  

  • 74. The antitumor effect of interferon in lymphocyte- and macrophage-depressed mice.
    Gresser I; Bourali-Maury C
    Proc Soc Exp Biol Med; 1973 Dec; 144(3):896-900. PubMed ID: 4358245
    [No Abstract]   [Full Text] [Related]  

  • 75. Effect of withaferin A on ehrlich ascites tumor cells. II. Target tumor cell destruction in vivo by immune activation.
    Shohat B; Joshua H
    Int J Cancer; 1971 Nov; 8(3):487-96. PubMed ID: 5002873
    [No Abstract]   [Full Text] [Related]  

  • 76. [Intensification of the oncolysis by clostridia by means of radio-frequency hyperthermy in experiments on animals--dependence on dosage and on intervals (author's transl)].
    Dietzel F; Gericke D
    Strahlentherapie; 1977 Apr; 153(4):263-6. PubMed ID: 857352
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immunization of mice to Sarcoma 180 and Ehrlich carcinoma with ultraviolet-killed tumor vaccine.
    Littman ML; Kim YC; Suk D
    Proc Soc Exp Biol Med; 1968 Jan; 127(1):7-17. PubMed ID: 5657038
    [No Abstract]   [Full Text] [Related]  

  • 78. Some properties of heavily irradiated EAT cells and their influence on the host.
    Jurásková V
    Br J Cancer; 1968 Mar; 22(1):63-9. PubMed ID: 5643004
    [No Abstract]   [Full Text] [Related]  

  • 79. Anticancer activity of zoanthids and the associated toxin, palytoxin, against Ehrlich ascites tumor and P-388 lymphocytic leukemia in mice.
    Quinn RJ; Kashiwagi M; Moore RE; Norton TR
    J Pharm Sci; 1974 Feb; 63(2):257-60. PubMed ID: 4149775
    [No Abstract]   [Full Text] [Related]  

  • 80. The cure and concomitant immunization of mice bearing Ehrlich ascites tumors by treatment with an antibody--alkylating agent complex.
    Flechner I
    Eur J Cancer (1965); 1973 Oct; 9(10):741-5. PubMed ID: 4803217
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.